Biosafety concerns for shared flow cytometry core facilities

Many researchers who need flow cytometry for their projects have neither sufficient funds nor the work volume to justify the purchase of an analytic cytometer or cell sorter. In shared flow cytometry facilities, costs for instrument purchases, cytometer maintenance, and personnel are pooled to provide economic services for a multitude of users when they are required. Owing to the diverse nature of the samples that are submitted to core facilities, the biohazard potential of the samples can vary dramatically. For the safety of facility personnel and users, it is critical that information about hazards contained in the samples be transmitted to instrument operators before flow cytometry experiments are started. During 1999 the former Biosafety Committee of the International Society for Analytical Cytology formulated a framework biosafety questionnaire for shared facilities designed to request information about the hazard potential of experimental samples from investigators who wish to use the facility. In this report we review safety issues that are pertinent to flow cytometry core facilities by discussing the individual components of this biosafety questionnaire. Cytometry Part A 56A:113–119, 2003. © 2003 Wiley‐Liss, Inc.

[1]  Mario Roederer,et al.  Measuring containment of viable infectious cell sorting in high‐velocity cell sorters , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[2]  I Schmid,et al.  Biosafety considerations for flow cytometric analysis of human immunodeficiency virus-infected samples. , 1999, Cytometry.

[3]  Fu-Der Wang,et al.  Analysis of Sharp-Edged Medical-Object Injuries at a Medical Center in Taiwan , 2000, Infection Control & Hospital Epidemiology.

[4]  J K Nicholson,et al.  Recovery of infectious human immunodeficiency virus from cells treated with 1% paraformaldehyde. , 1990, Journal of immunological methods.

[5]  S. W. Browning,et al.  Ability of 'OptiLyse' lysing/fixing reagents to inactivate HIV-infected H9 cells in whole blood. , 1994, Journal of immunological methods.

[6]  Vladislav J. Mikulich,et al.  Update on emerging infections: News from the Centers for Disease Control and Prevention , 2002 .

[7]  H. Drexler,et al.  Mycoplasma contamination in human leukemia cell lines. I. Comparison of various detection methods. , 1992, Journal of immunological methods.

[8]  Charles P. Gerba,et al.  Spread of viral infections by aerosols , 1987 .

[9]  R. Diamond,et al.  In Living Color: Protocols in Flow Cytometry and Cell Sorting , 2000 .

[10]  J. Lifson,et al.  Utility of formaldehyde fixation for flow cytometry and inactivation of the AIDS associated retrovirus. , 1986, Journal of immunological methods.

[11]  D. Ferber.  Monkey Virus Link to Cancer Grows Stronger , 2002, Science.

[12]  W. Heneine,et al.  Evidence of Infection with Simian Type D Retrovirus in Persons Occupationally Exposed to Nonhuman Primates , 2001, Journal of Virology.

[13]  M. Lairmore,et al.  Effects of whole blood lysis and fixation on the infectivity of human T-lymphotropic virus type 1 (HTLV-I). , 1994, Cytometry.

[14]  J. Mcdougal,et al.  Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus. , 1985, The Journal of infectious diseases.

[15]  T. Chen,et al.  Mycoplasma infection of cultured cells , 1989, Nature.

[16]  B Rachet,et al.  Cancer risk in laboratory workers: an emphasis on biological research. , 2000, American journal of industrial medicine.

[17]  Andrew S. Oberyszyn,et al.  Method for Visualizing Aerosol Contamination in Flow Sorters , 2002, Current protocols in cytometry.

[18]  P. Boffetta.  Carcinogenicity of trace elements with reference to evaluations made by the International Agency for Research on Cancer. , 1993, Scandinavian journal of work, environment & health.

[19]  F. Robertson,et al.  Novel rapid method for visualization of extent and location of aerosol contamination during high-speed sorting of potentially biohazardous samples. , 2001, Cytometry.

[20]  A. Panlilio,et al.  Experience of Healthcare Workers Taking Postexposure Prophylaxis After Occupational HIV Exposures: Findings of the HIV Postexposure Prophylaxis Registry , 2000, Infection Control & Hospital Epidemiology.

[21]  Steven Merlin.  Core Facility Management , 2000 .

[22]  J. Kappes,et al.  Safety Considerations in Vector Development , 2001, Somatic cell and molecular genetics.

[23]  J. Merrill.  Evaluation of selected aerosol-control measures on flow sorters. , 1981, Cytometry.

[24]  F. Rapp,et al.  Effects of cellular fixatives on human immunodeficiency virus production. , 1990, Cytometry.

[25]  P A Lopez,et al.  Basic aspects of high-speed sorting for clinical applications. , 2002, Cytotherapy.

[26]  S. Sattar,et al.  Development of methods to study the survival of airborne viruses , 1987, Journal of Virological Methods.

[27]  G. van den Engh,et al.  High-speed cell sorting: fundamentals and recent advances. , 2003, Current opinion in biotechnology.

[28]  J. Mcdougal,et al.  Inactivation of human T-lymphotropic virus type III/lymphadenopathy-associated virus by formaldehyde-based reagents , 1987, Applied and environmental microbiology.

[29]  H. Drexler,et al.  Elimination of mycoplasma from leukemia–lymphoma cell lines using antibiotics , 2002, Leukemia.

[30]  Martin-Martin Ls,et al.  Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus. , 1985 .

[31]  Daniela Vecchio,et al.  Occupational risk in health care and research. , 2003, American journal of industrial medicine.

[32]  C. Hewitt,et al.  Analysis of bacterial function by multi-colour fluorescence flow cytometry and single cell sorting. , 2000, Journal of microbiological methods.

[33]  Weiss Ra.  Why cell biologists should be aware of genetically transmitted viruses. , 1978 .

[34]  I Schmid,et al.  Biosafety guidelines for sorting of unfixed cells. , 1997, Cytometry.

[35]  R. Weiss.  Why cell biologists should be aware of genetically transmitted viruses. , 1978, National Cancer Institute monograph.

[36]  J. Ferbas,et al.  Testing the Efficiency of Aerosol Containment During Cell Sorting , 1997, Current protocols in cytometry.

[37]  H M Shapiro,et al.  Microbial analysis at the single-cell level: tasks and techniques. , 2000, Journal of microbiological methods.

[38]  J. Margolick,et al.  Assessment of aerosol containment on the ELITE flow cytometer. , 1995, Cytometry.

[39]  W. Emmett Barkley,et al.  Biosafety in microbiological and biomedical laboratories , 1984 .

[40]  D. Musher.  How contagious are common respiratory tract infections? , 2003, The New England journal of medicine.

[41]  R G Ashcroft,et al.  Commercial high speed machines open new opportunities in high throughput flow cytometry (HTFC). , 2000, Journal of immunological methods.

[42]  J. McSharry,et al.  Analysis of virus-infected cells by flow cytometry. , 2000, Methods.

[43]  Thomas Scheper,et al.  Flow cytometry in biotechnology , 2001, Applied Microbiology and Biotechnology.

[44]  N. B. Harris,et al.  Cell sorting of formalin-treated pathogenic Mycobacterium paratuberculosis expressing GFP. , 2002, BioTechniques.

[45]  G. Georgiou,et al.  Flow cytometric screening of cell-based libraries. , 2000, Journal of immunological methods.

[46]  S. W. Browning,et al.  Inactivation of HIV-infected H9 cells in whole blood preparations by lysing/fixing reagents used in flow cytometry. , 1993, Journal of immunological methods.

[47]  D. Henderson,et al.  Potential for laboratory exposures to biohazardous agents found in blood. , 1990, American journal of public health.

[48]  The management of occupational exposures to blood and body fluids: revised guidelines and new methods of implementation. , 2002, Annals of emergency medicine.